Professor John Campbell PhD FRSB shares insights into how treatment resistance in solid tumours can be overcome

Alex Blyth, CEO
21 minutes ago
1 min read

We spoke to Professor John Campbell PhD FRSB, a member of our Scientific Advisory Board, to discuss a key question in oncology: How can treatment resistance in solid tumours be overcome?

Recent Posts

See All

Dr. Mark A. Exley shares what excites him most about joining LIfT as Chief Scientific Officer and the potential of LIfT’s technology

LIfT BioSciences Appoints Mark A. Exley as Chief Scientific Officer

Dr Michael McCarthy discusses one of the biggest challenges in solid tumour treatment: treatment resistance

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.

Professor John Campbell PhD FRSB shares insights into how treatment resistance in solid tumours can be overcome

Recent Posts

Comments

Stay up-to-date with our progress and latest news

Company

Quick Links